Kawanishi, Japan

Masaru Suzuki

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaru Suzuki. Retrieved from https://idiyas.com/inventor/masaru-suzuki-ldn99s8n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaru Suzuki: Innovator in Biochemical Engineering

Introduction

Masaru Suzuki is a notable inventor based in Kawanishi, Japan. He has made significant contributions to the field of biochemical engineering, particularly in the area of gene and promoter technology. His work has implications for the production of important pharmaceuticals.

Latest Patents

Masaru Suzuki holds a patent for the glyceraldehyde-3-phosphate dehydrogenase gene and promoter. This patent discloses a promoter of a glyceraldehyde-3-phosphate dehydrogenase gene of Acremonium chrysogenum. It also includes a transformant obtained by using the expression plasmid containing the promoter, which is capable of producing cephalosporin.

Career Highlights

He is currently associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His work at Takeda has allowed him to focus on innovative solutions in drug development and production.

Collaborations

Masaru Suzuki has collaborated with notable colleagues such as Yasuhiro Sumino and Hiroyuki Kimura. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Masaru Suzuki's contributions to biochemical engineering and his innovative patent work highlight his role as a key inventor in the pharmaceutical industry. His ongoing efforts continue to influence the development of important medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…